Trial Profile
Study of effects on the retina morphological changes and vision of Aflibercept intravitreal injection in patients with macular edema due to central retinal vein occlusion.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Mar 2019
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Central retinal vein occlusion; Retinal oedema
- Focus Therapeutic Use
- 15 Mar 2019 Status changed from recruiting to completed.
- 11 Jul 2014 New trial record